How effective is metformin in reducing cardiovascular risks in adults with T2DM?

dc.contributor.authorAhsani, Navid
dc.contributor.authorWilliams, Ashley P.
dc.contributor.departmentFamily Medicine, School of Medicineen_US
dc.date.accessioned2022-06-29T20:09:50Z
dc.date.available2022-06-29T20:09:50Z
dc.date.issued2021-10
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationAhsani, N., & Williams, A. P. (2021). How effective is metformin in reducing cardiovascular risks in adults with T2DM? Evidence-Based Practice, 24(10), 36–37. https://doi.org/10.1097/EBP.0000000000001242en_US
dc.identifier.issn2473-3717en_US
dc.identifier.urihttps://hdl.handle.net/1805/29458
dc.language.isoenen_US
dc.publisherWolters Kluweren_US
dc.relation.isversionof10.1097/EBP.0000000000001242en_US
dc.relation.journalEvidence-Based Practiceen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectmetforminen_US
dc.subjectcardiovascular risksen_US
dc.subjectadultsen_US
dc.titleHow effective is metformin in reducing cardiovascular risks in adults with T2DM?en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ahsani2021How-AAM.pdf
Size:
146.61 KB
Format:
Adobe Portable Document Format
Description:
Author's Manuscript
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: